Influx Healthtech Limited — Important, 10-07-2026: Updates

Influx Healthtech reported strong Q1 growth, driven by nutraceuticals. It invested ₹10 Cr to expand its nutraceutical facility to 75,000 sq. ft., aiming for a 2.5x capacity increase by August. New lines for beverages and pet nutrition were also added. Management guides FY27 topline growth at 25-30% and EBITDA margins at 20-22%.